hFCGR1A/hFCGR2B

Nomenclature

C57BL/6JSmo-Fcgr1tm3(hFCGR1A)Fcgr2btm3(hFCGR2B)Smoc

Cat. NO.

NM-XA-253155

Strain State

Repository Live

Export PDF

Model Description

The hFCGR1A (NM-HU-2000072) was crossed with hFCGR2B(NM-HU-2000010) to generate hFCGR1A/hFCGR2B mice.

Validation Data

a95f4cbe-a667-4ab8-81af-70d8bdd52af5.png

Fig.1 Detection of FCGR1A expression in subcutaneous fat pad, bladder and liver by RT-PCR. Subcutaneous fat pad, bladder and liver RNA was extracted from 8-week-old male WT C57BL/6 (WT)(n=2) and homozygous hFCGR1A/hFCGR2B mice (HO/WT) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 

Abbr. M, marker; HO, homozygous; WT, wild type.

262cbaee-8157-4612-b38f-58a086314b35.png

Fig.2 Detection of FCGR2B expression in liver, brain, spleen and bone marrow by RT-PCR. Liver, brain, spleen and bone marrow RNA was extracted from 12-week-old male wild-type C57BL/6 (WT)(n=2) and heterozygous hFCGR1A/hFCGR2B mice (HE/HE) (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers. 


Abbr. M, marker; HE, heterozygous; WT, wild type.

1068057e-7d8e-4c25-aacf-35f5f879746a.png

Fig.3 Detection of hFCGR2B and mFCGR2B expression on macrophages,monocytes and B cells in spleen of WT C57BL/6 mice and WT/HO hFCGR1A/hFCGR2B mice by FACS.

Leukocytes were collected from wild-type C57BL/6 mice (female, 8 weeks old) and  WT/HO hFCGR1A/hFCGR2B humanized mice (female, 9 weeks old), and analyzed by flow cytometry with anti-mCD32 and anti-hCD32. 

Abbr. HO, homozygous; WT, wild type.

da1d246e-5e6e-4011-aa09-b57949954e8f.png

Fig.4 Detection of hFCGR2B and mFCGR2B expression on macrophages,monocytes and B cells in blood of WT C57BL/6 mice and WT/HO hFCGR1A/hFCGR2B mice by FACS.

Leukocytes were collected from wild-type C57BL/6 mice (female, 8 weeks old) and WT/HO hFCGR1A/hFCGR2B humanized mice (female, 9 weeks old), and analyzed by flow cytometry with anti-mCD32 and anti-hCD32. 

Abbr. HO, homozygous; WT, wild type.



You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more

Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

Learn more